Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

1 min read

May Image of the Month

YOU BE THE CARDIAC IMAGING SPECIALIST!

What abnormality is demonstrated in this color flow Doppler echocardiogram?

ANSWER

Functional Mitral Regurgitation!

In the presence of heart disease, the mitral annulus can dilate to the point where the leaflets of the mitral valve no longer meet to create a seal (coapt). When this happens, blood can flow backward into the atrium during cardiac systole, creating mitral regurgitation. In the absence of frank pathology to the mitral valve itself, this form of backward flow is called Functional Mitral Regurgitation (FMR).

This FMR was seen in a sheep and this image of the heart was acquired using IMMR’s X8-2t TEE probe on an EPIQ machine, with great spatial and temporal resolution.

Mitral regurgitation (MR) can result from various abnormalities of the mitral valve. It is the most common valvular abnormality worldwide, affecting over 2% of the total population. Severe mitral valve regurgitation can lead to complications, including heart failure, atrial fibrillation and pulmonary hypertension. Treatment of MR with mitral valve repair or replacement devices is often indicated.

Large animal models are invaluable in MedTech research for the investigation of the pathophysiology of mitral regurgitation. When it comes to choose the relevant animal models for preclinical validation of novel mitral devices, intimate knowledge of comparative anatomy is a key competency for obtaining meaningful results.

Contact us to learn more and discuss your preclinical research and pathology needs.

June Image of the Month

1 min read

June Image of the Month

You be the Pathologist! What is abnormal in this native mitral valve leaflet? Answer A bone has formed in this native mitral valve...

Read More

One Minute With the Expert

We sat down with Dr. Olivier Chevènement, DVM, PhD, Veterinary Surgeon and Study Director at Veranex to discuss comparative anatomy of the...

Read More
April Image of the Month

1 min read

April Image of the Month

You be the Pathologist! Where was this bone seen? Answer In the heart! It is called os cordis. Indeed, some animals (mostly ruminants)...

Read More